How Complementary Roles in Clinic and Industry Illuminate Avenues for Patient-Centered Cancer Care: With D. Ross Camidge, MD, PhD; and Geoff Oxnard, MD

,

Drs. Camidge and Oxnard discuss novel EGFR inhibitors, the role of precision medicine in early cancer detection, and balancing clinical and industry roles.

How This Is Building Me, hosted by world-renowned oncologist D. Ross Camidge, MD, PhD, is a podcast focused on the highs and lows, ups and downs of all those involved with cancer, cancer medicine, and cancer science across the full spectrum of life’s experiences.

In this episode, Dr Camidge sat down with Geoff Oxnard, MD, chief medical officer at Blossom Hill Therapeutics and a thoracic oncologist at Boston Medical Center in Massachusetts.

Drs Camidge and Oxnard discussed Dr Oxnard's work with novel EGFR inhibitors that aims to overcome treatment resistance; how advancements in precision medicine have increased the importance of early cancer detection; and how he balances clinical practice with his industry role, advocating for efficient, patient-centered care.